9-101424931-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PM5PP3

The NM_000035.4(ALDOB):​c.911G>A​(p.Arg304Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000308 in 1,614,138 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R304W) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00033 ( 0 hom. )

Consequence

ALDOB
NM_000035.4 missense

Scores

13
5
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:3U:10

Conservation

PhyloP100: 7.91
Variant links:
Genes affected
ALDOB (HGNC:417): (aldolase, fructose-bisphosphate B) Fructose-1,6-bisphosphate aldolase (EC 4.1.2.13) is a tetrameric glycolytic enzyme that catalyzes the reversible conversion of fructose-1,6-bisphosphate to glyceraldehyde 3-phosphate and dihydroxyacetone phosphate. Vertebrates have 3 aldolase isozymes which are distinguished by their electrophoretic and catalytic properties. Differences indicate that aldolases A, B, and C are distinct proteins, the products of a family of related 'housekeeping' genes exhibiting developmentally regulated expression of the different isozymes. The developing embryo produces aldolase A, which is produced in even greater amounts in adult muscle where it can be as much as 5% of total cellular protein. In adult liver, kidney and intestine, aldolase A expression is repressed and aldolase B is produced. In brain and other nervous tissue, aldolase A and C are expressed about equally. There is a high degree of homology between aldolase A and C. Defects in ALDOB cause hereditary fructose intolerance. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrnull-null-null-null is described in UniProt as null.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.806

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ALDOBNM_000035.4 linkuse as main transcriptc.911G>A p.Arg304Gln missense_variant 8/9 ENST00000647789.2 NP_000026.2 P05062A0A024R145

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ALDOBENST00000647789.2 linkuse as main transcriptc.911G>A p.Arg304Gln missense_variant 8/9 NM_000035.4 ENSP00000497767.1 P05062
ALDOBENST00000648064.1 linkuse as main transcriptc.911G>A p.Arg304Gln missense_variant 8/9 ENSP00000497990.1 P05062
ALDOBENST00000648758.1 linkuse as main transcriptc.911G>A p.Arg304Gln missense_variant 8/9 ENSP00000497731.1 P05062
ALDOBENST00000649902.1 linkuse as main transcriptc.911G>A p.Arg304Gln missense_variant 7/7 ENSP00000497216.1 A0A3B3IS80

Frequencies

GnomAD3 genomes
AF:
0.000138
AC:
21
AN:
152158
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000215
AC:
54
AN:
251216
Hom.:
0
AF XY:
0.000184
AC XY:
25
AN XY:
135764
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000308
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000326
AC:
476
AN:
1461862
Hom.:
0
Cov.:
33
AF XY:
0.000325
AC XY:
236
AN XY:
727236
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.000335
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000401
Gnomad4 OTH exome
AF:
0.000132
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152276
Hom.:
0
Cov.:
33
AF XY:
0.000134
AC XY:
10
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.0000481
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000176
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000177
Hom.:
0
Bravo
AF:
0.000189
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000198
AC:
24
EpiCase
AF:
0.000164
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hereditary fructosuria Pathogenic:3Uncertain:5
Likely pathogenic, no assertion criteria providedresearchDivision of Human Genetics, Children's Hospital of PhiladelphiaJan 31, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 02, 2022This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 304 of the ALDOB protein (p.Arg304Gln). This variant is present in population databases (rs145078268, gnomAD 0.04%). This missense change has been observed in individual(s) with hereditary fructose intolerance (PMID: 10970798). This variant is also known as p.Arg303Gln. ClinVar contains an entry for this variant (Variation ID: 417929). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Experimental studies have shown that this missense change affects ALDOB function (PMID: 10970798). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Likely pathogenic, criteria provided, single submitterclinical testingVictorian Clinical Genetics Services, Murdoch Childrens Research InstituteMar 31, 2022Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as likely pathogenic. The following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with hereditary fructose intolerance (MIM#229600). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to glutamine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (58 heterozygotes, 0 homozygotes). (SP) 0309 - Two alternative amino acid changes at the same position have been observed in gnomAD (v2) (highest allele count: 3 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools and very highly conserved with a minor amino acid change. (SP) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (I) 0809 - Previous evidence of pathogenicity for this variant is inconclusive. This variant has been reported as VUS and likely pathogenic in ClinVar. It has also been reported in a heterozygous individual with hereditary fructose intolerance (PMID: 10970798). (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1002 - This variant has moderate functional evidence supporting abnormal protein function. Functional studies demonstrated reduced catalytic efficiency of the protein (PMID: 10970798). (SP) 0704 - Another missense variant comparable to the one identified in this case has limited previous evidence for pathogenicity. An alternative change to a tryptophan has been reported in a homozygous individual with hereditary fructose intolerance (PMID: 8880583). It was subsequently shown to impair normal enzyme activities (PMID: 10970798). It has also been reported as VUS and pathogenic in ClinVar. (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 28, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsApr 27, 2022- -
Likely pathogenic, no assertion criteria providedliterature onlyATS em Genética Clínica, Universidade Federal do Rio Grande do SulMar 18, 2021- -
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Jan 19, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingMyriad Genetics, Inc.Nov 01, 2021NM_000035.3(ALDOB):c.911G>A(R304Q) is a missense variant classified as a variant of uncertain significance in the context of hereditary fructose intolerance. R304Q has been observed in a case with relevant disease (PMID: 10970798). Functional assessments of this variant are available in the literature (PMID: 10970798). R304Q has been observed in population frequency databases (gnomAD: AMR 0.04%). In summary, there is insufficient evidence to classify NM_000035.3(ALDOB):c.911G>A(R304Q) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicApr 17, 2023PP3 -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 02, 2024Identified as a single heterozygous variant in an individual with hereditary fructose intolerance; reported as R303Q due to alternate nomenclature (PMID: 10970798); Published functional studies demonstrate impaired enzyme activity (PMID: 10970798); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 22995991, 21228398, 31589614, 37743645, 34524712, 20848650, 35460079, 36028839, 36890159, 10970798) -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 05, 2022Variant summary: ALDOB c.911G>A (p.Arg304Gln) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00021 in 251216 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ALDOB causing Hereditary Fructose Intolerance (0.00021 vs 0.0045), allowing no conclusion about variant significance. c.911G>A has been reported in the literature without a second allele detected in at-least one individual affected with Hereditary Fructose Intolerance (example, Santamaria_2000). These report(s) do not provide unequivocal conclusions about association of the variant with Hereditary Fructose Intolerance. At least one publication reports experimental evidence evaluating an impact on protein function (example, Santamaria_2000). The most pronounced variant effect results in impaired but not abolished catalytic efficiency in-vitro towards Fructose 1,6-bisphosphate and Fructose 1-phosphate as substrates as evidenced by decreased specific activity, increased Km, decreased Kcat and increased Kcat/Km. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments. Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 08, 2022The c.911G>A (p.R304Q) alteration is located in exon 8 (coding exon 7) of the ALDOB gene. This alteration results from a G to A substitution at nucleotide position 911, causing the arginine (R) at amino acid position 304 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
ALDOB-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 13, 2024The ALDOB c.911G>A variant is predicted to result in the amino acid substitution p.Arg304Gln. This variant is also referred to as R303Q in the literature. This variant was reported in the heterozygous state in an individual with hereditary fructose intolerance ((Santamaria et al. 2000. PubMed ID: 10970798). In that patient, this variant was inherited from the patient’s presumably unaffected mother. Additional functional studies showed that this variant impacts ALDOB protein function (Santamaria et al. 2000. PubMed ID: 10970798). Of note, another variant impacting the same amino acid was reported in the homozygous state in an individual with hereditary fructose intolerance (Santamaria et al. 1996. PubMed ID: 8880583). This variant is reported in 0.037% of alleles in individuals of Latino descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Pathogenic
0.19
D
BayesDel_noAF
Pathogenic
0.35
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.93
D;D;D;D;.
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.94
.;.;.;D;D
M_CAP
Uncertain
0.24
D
MetaRNN
Pathogenic
0.81
D;D;D;D;D
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Pathogenic
4.0
H;H;H;H;.
PrimateAI
Uncertain
0.76
T
PROVEAN
Uncertain
-2.9
D;.;.;.;.
REVEL
Pathogenic
0.91
Sift
Uncertain
0.016
D;.;.;.;.
Sift4G
Pathogenic
0.0
D;.;.;.;.
Polyphen
0.99
D;D;D;D;.
Vest4
0.98
MVP
0.95
MPC
0.13
ClinPred
0.75
D
GERP RS
4.8
Varity_R
0.83
gMVP
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.42
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.42
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145078268; hg19: chr9-104187213; COSMIC: COSV105314591; COSMIC: COSV105314591; API